Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Mol Endocrinol
; 29(2): 322-31, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-25496033
Full text:
1
Database:
MEDLINE
Main subject:
Superoxide Dismutase
/
Receptors, Cytoplasmic and Nuclear
/
MAP Kinase Signaling System
/
JNK Mitogen-Activated Protein Kinases
/
Carcinogenesis
/
Liver Neoplasms
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Mol Endocrinol
Journal subject:
BIOLOGIA MOLECULAR
/
ENDOCRINOLOGIA
Year:
2015
Type:
Article